Skip to main content
SpringerLink
Log in

Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders

Implications of Access, Effectiveness, and Contextual Treatment

  • Commentary
  • Published:
Pediatric Drugs Aims and scope Submit manuscript

Abstract

Practice guidelines for the treatment of youth with mental health problems tend to endorse integrating psychopharmacologic treatment with psychosocial interventions, such as psychotherapy and parent skills training. However, poor access to pediatric mental health specialists and inadequate training of primary care physicians in psychosocial interventions make it difficult for families to receive this standard of care. Large pediatric randomized, multicenter trials, including the Multimodal Treatment Study of ADHD (attention deficit hyperactivity disorder) [MTA] and the Treatment for Adolescents with Depression Study (TADS), have begun to identify specific advantages of multimodal treatment compared with psychopharmacology alone. Advantages of combined treatment include improvement of both symptoms and family functioning. More research is needed to determine effective and appropriate multimodal interventions for complex and severe pediatric mental illness. Advantages of multimodal treatment must be balanced with the treatment burden on the family system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Similar content being viewed by others

References

  1. Report of the Working Group on Psychotropic Medications for Children and Adolescents: psychopharmacological, psychosocial, and combined interventions for childhood disorders: evidence base, contextual factors, and future directions [online]. Available from URL: http://www.apa.org/pi/cyf/childmeds.pdf [Accessed 2008 Oct 15]

  2. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007 Feb; 46(2): 267–83

    Google Scholar 

  3. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2007 Jan; 46(1): 107–25

    Google Scholar 

  4. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007 Nov; 46(11): 1503–26

    Google Scholar 

  5. Ma J, Lee KV, Stafford RS. Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 2005 Dec; 37(6): 434–42

    Article  PubMed  Google Scholar 

  6. Leigh H, Stewart D, Mallios R. Mental health and psychiatry training in primary care residency programs: part II. What skills and diagnoses are taught, how adequate, and what affects training directors’ satisfaction? Gen Hosp Psychiatry 2006 May–Jun; 28(3): 195–204

    Article  PubMed  Google Scholar 

  7. Richardson LP, Lewis CW, Casey-Goldstein M, et al. Pediatric primary care providers and adolescent depression: a qualitative study of barriers to treatment and the effect of the black box warning. J Adolesc Health 2007 May; 40(5): 433–9

    Article  PubMed  Google Scholar 

  8. Kim WJ. Child and adolescent psychiatry workforce: a critical shortage and national challenge. Acad Psychiatry 2003 Winter; 27(4): 277–82

    Article  PubMed  CAS  Google Scholar 

  9. Foster EM, Jensen PS, Schlander M, et al. Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res 2007 Feb; 42: 165–82

    Article  PubMed  Google Scholar 

  10. Vitiello B. An update on publicly funded multisite trials in pediatric psychopharmacology. Child Adolesc Psychiatric Clin N Am 2006; 15: 1–12

    Article  Google Scholar 

  11. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder (ADHD). Arch Gen Psychiatry 1999a Dec; 56(12): 1073–86

    Article  Google Scholar 

  12. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004 Aug; 292(7): 807–20

    Article  PubMed  CAS  Google Scholar 

  13. Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996 Oct; 35(10): 1304–13

    Article  PubMed  CAS  Google Scholar 

  14. Pelham WE, Hoza B. Intensive treatment: a summer treatment program for children with ADHD. In: Hibbs ED, Jensen PS, editors. Psychosocial treatments for empirically-based strategies for clinical practice. New York: American Psychological Association, 1996: 311–40

    Chapter  Google Scholar 

  15. Conners CK, Epstein JN, March JS, et al. Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 2001 Feb; 40(2): 159–67

    Article  PubMed  CAS  Google Scholar 

  16. Wells KC, Chi TC, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2006 Aug; 74(4): 649–57

    Article  PubMed  Google Scholar 

  17. Patterson GR, Reid JB, Dishion TJ. Antisocial boys: Vol. 4. A social interactional approach. Eugene (OR): Castalia, 1992

    Google Scholar 

  18. Pierce EW, Ewing LJ, Campbell SB. Diagnostic status and symptomatic behavior of hard-to-manage preschool children in middle childhood and early adolescence. J Clin Child Psychol 1999 Mar; 28(1): 44–57

    Article  PubMed  CAS  Google Scholar 

  19. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics 2004; 113(4): 754–61

    Article  Google Scholar 

  20. The MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004; 113(4): 762–9

    Article  Google Scholar 

  21. Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA Study. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 988–1002

    Article  Google Scholar 

  22. Molina BS, Flory K, Hinshaw SP, et al. Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 1028–40

    Article  PubMed  Google Scholar 

  23. Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 2007 Aug; 46(8): 1003–14

    Article  PubMed  Google Scholar 

  24. The Treatment for Adolescents with Depression Study Team. Treatment for Adolescents with Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 2003 May; 42(5): 531–42

    Article  Google Scholar 

  25. March J, Silva S, Vitiello B, et al. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 2006 Dec; 45(12): 1393–403

    Article  PubMed  Google Scholar 

  26. Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study. J Am Acad Child Adolesc Psychiatry 2006; 45(12): 1404–11

    Article  PubMed  Google Scholar 

  27. Hollon SD, Garber J, Shelton RC. Treatment ofdepression in adolescents with cognitive behavior therapy and medications: a commentary on the TADS project. Cogn Behav Pract 2005; 12(2): 149–55

    Article  Google Scholar 

  28. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007 Oct; 64(10): 1132–44

    Article  PubMed  CAS  Google Scholar 

  29. Hack S, Chow B. Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. J Child Adolesc Psychopharmacol 2001 Spring; 11(1): 59–67

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr G. Reeves’ work was supported by a grant from the National Institute of Mental Health (1K12RR023240-01). Dr B. Anthony’s work was supported by a grant from the National Institute of Mental Health (K23 MH01899).

The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. Child and Adolescent Psychiatry Division, University of Maryland, 701 W. Pratt Street, Baltimore, Maryland, 21201, USA

    Gloria Reeves & Bruno Anthony

Authors
  1. Gloria Reeves
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruno Anthony
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gloria Reeves.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reeves, G., Anthony, B. Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders. Pediatr-Drugs 11, 165–169 (2009). https://doi.org/10.2165/00148581-200911030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00148581-200911030-00002

Keywords

Search

Navigation